[{"NetIncomeLoss_1_Q1_USD":-61298000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":57747168.0,"CommitmentsAndContingencies_0_Q1_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":673000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":833000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":43000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":129300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":123908000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":8548000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":30000.0,"AssetsCurrent_0_Q1_USD":546632000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":222000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7556755.0,"SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":6800000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":936000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_1_Q1_USD":68000.0,"CommonStockSharesIssued_0_Q1_shares":57901020.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":5065000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":300527000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":30747000.0,"Assets_0_Q1_USD":595246000.0,"Liabilities_0_Q1_USD":92233000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":28444000.0,"InvestmentsAndCash_0_Q1_USD":502200000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":156370000.0,"InventoryWriteDown_1_Q1_USD":100000.0,"AssetsFairValueDisclosure_0_Q1_USD":462008000.0,"RestrictedInvestmentsNoncurrent_0_Q1_USD":3102000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":196000.0,"AccountsReceivableNetCurrent_0_Q1_USD":21821000.0,"CommonStockValue_0_Q1_USD":579000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1318157000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":1000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":9524000.0,"CostsAndExpenses_1_Q1_USD":86650000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1973000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":49344000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-61266000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-433000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":201648000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":732000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":55681000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":32000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":35879000.0,"CommonStockSharesOutstanding_0_Q1_shares":57901020.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":31825000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":32000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":11119000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":5548000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":2000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-67682000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":1352000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":7925000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":65750000.0,"AccountsPayableCurrent_0_Q1_USD":11905000.0,"NonoperatingIncomeExpense_1_Q1_USD":196000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":201648000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":15546000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":936000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":411000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":9633000.0,"LiabilitiesCurrent_0_Q1_USD":63789000.0,"ShareBasedCompensation_1_Q1_USD":11119000.0,"MarketableSecurities_0_Q1_USD":300527000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_1_Q1_USD":26000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":8588000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"IncreaseDecreaseOfRestrictedInvestments_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3057000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":25156000.0,"OperatingIncomeLoss_1_Q1_USD":-61494000.0,"InventoryNet_0_Q1_USD":7090000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-815766000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":595246000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":11119000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2540000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-9384000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.06,"StockholdersEquity_0_Q1_USD":503013000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":637000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":300485000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-365000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":6488000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4520000.0,"Ticker":"DCPH","CIK":"1654151","name":"DECIPHERA PHARMACEUTICALS, INC.","OfficialName":"Deciphera Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"586694767.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]